Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Oxaliplatin in Recurrent or Metastatic Breast Cancer
NCT01351597Phase 2Unknown
- Sponsor
- Korean Breast Cancer Study Group
- Start
- Apr 2011
- Primary completion
- Apr 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, oxaliplatin in breast cancer, sponsored by Korean Breast Cancer Study Group. Status: unknown.
02
Drugs
docetaxeloxaliplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01351597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01351597.